Literature DB >> 24357456

MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1.

Jun Yang1, Heng Zhao, Yu Xin, Limin Fan.   

Abstract

Lung cancer is the most common cause of death from cancer worldwide and recent studies have revealed that microRNAs play critical roles to regulate lung carcinogenesis. Here we present evidence to show the role of miR-198 in lung cancer development. Our results showed that ectopic expression of miR-198 inhibits the viability and induces the apoptosis of human non-small cell lung cancer cells A549 and NCI-H460, while miR-198 inhibition resulted in opposite changes. In nude mice miR-198 inhibits A549 growth of tumor graft. We further demonstrated that miR-198 directly targets fibroblast growth factor receptor 1 (FGFR1) in lung cancer cells. Restoring FGFR1 expression blocked the inhibitory function of miR-198, while FGFR1 inhibition achieved the similar phenotypes of miR-198 overexpression. Hence, our data delineates the molecular pathway by which miR-198 inhibits lung cancer cellular proliferation and induces apoptosis, and may have important implication for the treatment of lung carcinogenesis.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  APOPTOSIS; FGFR1; LUNG CARCINOGENESIS; VIABILITY; miR-198

Mesh:

Substances:

Year:  2014        PMID: 24357456     DOI: 10.1002/jcb.24742

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  32 in total

1.  MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a.

Authors:  Chengshan Xu; Ling Zhang; Hengheng Li; Zhihua Liu; Lianning Duan; Chengrong Lu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1.

Authors:  Yingbin Hu; Ziyuan Tang; Bonian Jiang; Juying Chen; Zhongpin Fu
Journal:  Oncol Lett       Date:  2017-02-02       Impact factor: 2.967

Review 3.  Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.

Authors:  Qian Bai; Zhenjie Pan; Ghulam Nabi; Farooq Rashid; Yang Liu; Suliman Khan
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

4.  The promising role and prognostic value of miR-198 in human diseases.

Authors:  Xiaoping Wang; Yanxia Zhu; Qiuli Xie
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

5.  MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4.

Authors:  Yuanyuan Kang; Ying Zhang; Yan Sun
Journal:  Int J Oncol       Date:  2021-05-13       Impact factor: 5.650

6.  miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5.

Authors:  Chao Yuan; Zhenhong Su; Shengjie Liao; Duanzhuo Li; Zhiwen Zhou; Yawen Wang; Mingchun Quan; Lingling Zeng; Cai Lv; Chenyi Shen; Weida Gong; Jianfeng Wu; Xiaogang Chen; Wenbing Hu; Xu Lv; Wenxia Si; Xin Yu
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

7.  Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer.

Authors:  Jianzhang Wu; Tao Wei; Qinqin Tang; Bixia Weng; Wulan Li; Xin Jiang; Ting Ding; Xiaokun Li; Guang Liang; Yuepiao Cai; Jiansong Ji
Journal:  BMC Cancer       Date:  2015-04-12       Impact factor: 4.430

8.  miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma.

Authors:  Shujun Wu; Guojun Zhang; Ping Li; Shanshan Chen; Furui Zhang; Juan Li; Chenyang Jiang; Xiaonan Chen; Yuanyuan Wang; Yuwen Du; Qianqian Sun; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2015-11-09

9.  miR-198 Represses the Proliferation of HaCaT Cells by Targeting Cyclin D2.

Authors:  Jian Wang; Guorong Dan; Tao Shangguan; Han Hao; Ran Tang; Kaige Peng; Jiqing Zhao; Huiqin Sun; Zhongmin Zou
Journal:  Int J Mol Sci       Date:  2015-07-27       Impact factor: 5.923

Review 10.  The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment.

Authors:  Norahayu Othman; Noor Hasima Nagoor
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.